Ministry of Food and Drug Safety Releases "2025 Medical Narcotics Handling Statistics"
Growth in ADHD Medication Prescriptions Slowing... Appetite Suppressant Use Also Declines

It was found that 4 out of 10 people in Korea were prescribed medical narcotics last year. However, the number of patients prescribed certain narcotics, such as fentanyl patches—which had been a source of particular concern regarding misuse—has noticeably decreased, thanks to strengthened government oversight.

4 Out of 10 Koreans Prescribed Medical Narcotics... Fentanyl Use Down 35% View original image

On June 24, the Ministry of Food and Drug Safety and the Korea Institute of Drug Safety & Risk Management announced the "2025 Statistics on the Handling Status of Medical Narcotics." This is based on an analysis of integrated data reported over the past year by 49,117 domestic handlers of narcotics.


According to the statistics, over the past five years, the number of patients prescribed medical narcotics has steadily increased, reaching 20.2 million (excluding duplicates) last year. This means that 4 out of every 10 people in Korea received at least one prescription for medical narcotics. Among them, 12.62 million people were prescribed anesthetics such as propofol, and 9.72 million received hypnotics and sedatives such as midazolam and zolpidem. By age group, those in their 50s accounted for the largest portion at 4.15 million (20.5%), followed by those in their 60s (3.96 million) and 40s (3.82 million). Patients in their 40s to 60s made up 59% of the total.


Last year, there were approximately 100 million prescriptions for medical narcotics, with a total of 1.95724 billion tablets prescribed. On average, each patient was prescribed 97 tablets of medical narcotics. By therapeutic category, anxiolytics accounted for the largest number of prescriptions at 923.82 million tablets, followed by hypnotics and sedatives (325.12 million), antiepileptics (252.43 million), and appetite suppressants (213.72 million).


However, ingredients that are the focus of the government's intensive management to prevent misuse showed a declining trend. In particular, the number of patients prescribed fentanyl patches—where it has become mandatory to check a patient's medication history before prescribing—decreased by 35.7% within two years of the policy's implementation.


The number of patients prescribed appetite suppressants and the volume of such prescriptions also continued to decline. Last year, the number of tablets prescribed was 213.71 million, a decrease of 12.8% compared to 2021. The Ministry of Food and Drug Safety analyzed that, in addition to policies to prevent the misuse of medical narcotics, the increased use of GLP-1 (glucagon-like peptide-1) class obesity treatments also contributed to this trend.


4 Out of 10 Koreans Prescribed Medical Narcotics... Fentanyl Use Down 35% View original image
4 Out of 10 Koreans Prescribed Medical Narcotics... Fentanyl Use Down 35% View original image

In contrast, prescriptions for methylphenidate, a treatment for ADHD (attention deficit hyperactivity disorder), reached 108.16 million tablets last year, an increase of 138.3% compared to 2021, with the number of patients prescribed rising to 392,239. However, the annual rate of increase has been gradually slowing, from 29.9% in 2022, 26.7% in 2023, 20.3% in 2024, to 16.2% in 2025. A representative from the Ministry of Food and Drug Safety stated, "Methylphenidate carries a high risk of side effects and addiction if misused for purposes other than treatment, such as cognitive enhancement. We will strengthen education for adolescents and parents and intensify monitoring of suspected misuse cases to enhance oversight going forward."


To prevent excessive or duplicate prescriptions, the Ministry is gradually expanding the scope of patients whose medication history must be checked before prescribing. After adding fentanyl last year, methylphenidate and appetite suppressants have been included this year, and zolpidem and propofol will be added next year. On the day of prescribing, information will be accessible to prescribers through the Drug Utilization Review (DUR) system, in collaboration with the Health Insurance Review and Assessment Service.



In addition, the Ministry plans to establish an integrated surveillance system for narcotics misuse (K-NASS) using artificial intelligence (AI) by the end of the year, aiming to improve the efficiency of supervising companies and institutions suspected of misuse. The Ministry official stressed, "By analyzing approximately one billion records of narcotics handling data, we will establish effective policies to prevent misuse and create an environment where the public can feel safe from the risks of narcotic misuse."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing